CION Ameerpet
Newly diagnosed or still investigating? This guide explains the blood tests used in lymphoma — what each one checks, why an LDH or CBC result matters, and, just as importantly, what blood work can and cannot tell you about lymphoma.
If lymphoma is suspected, a set of blood tests is almost always among the first things ordered. They are quick, low-risk and give doctors an early read on your general health, whether any blood cells or organs are affected, and how much disease might be present. But there is one thing they cannot do: blood tests alone cannot diagnose lymphoma. That confirmation needs tissue — a lymph node biopsy examined by a pathologist.
So it helps to think of blood tests lymphoma work-up as the supporting cast, not the lead. A complete blood count (CBC), a lactate dehydrogenase (LDH) level and a handful of chemistry and viral tests build the picture around the diagnosis: they flag anaemia or low platelets, hint at how active the disease is, protect you during treatment, and give a baseline to monitor against. This page walks through each test, what it checks, and how CION's haematology team reads your lymphoma blood work in context.
For the bigger picture, see our Lymphoma hub, and if you are moving toward a plan, our Lymphoma Treatment in Hyderabad page.
A completely normal blood count does not rule out lymphoma. Many people with lymphoma — particularly early or localised disease — have an entirely normal CBC, because the lymphoma sits in lymph nodes rather than in the bloodstream. This is exactly why guidelines from NCCN and ESMO require a tissue biopsy, not blood tests, to make the diagnosis. A persistent, unexplained lump should never be dismissed on the basis of normal bloods alone. (Source: NCCN and ESMO clinical practice guidelines for Hodgkin and non-Hodgkin lymphoma.)
No single test tells the whole story. Together, these bloods help build the clinical picture, plan safe treatment and set a baseline to monitor against.
| Blood test | What it checks | Why it matters in lymphoma |
|---|---|---|
| CBC (complete blood count) | Red cells, white cells, platelets | Flags anaemia, low platelets or abnormal white cells — may hint at marrow involvement; often normal early on |
| Peripheral blood smear | Blood film under the microscope | Looks at cell appearance and can occasionally spot circulating abnormal lymphocytes |
| LDH (lactate dehydrogenase) | An enzyme released by fast cell turnover | A raised level can reflect tumour burden or a faster-growing lymphoma; used in prognostic scores |
| Kidney & liver function | Creatinine, electrolytes, liver enzymes | Confirms organs are working before treatment; guides safe drug dosing |
| Uric acid | Product of rapid cell breakdown | Helps anticipate and prevent problems when a large, fast lymphoma is treated |
| Viral screen (HIV, hepatitis B & C) | Infection status | Changes the treatment approach and protects against hepatitis reactivation during antibody therapy |
This table is a general guide; the exact panel is tailored to your situation. Results vary by individual and are always interpreted together with your scans and biopsy. Testing follows NCCN and ESMO lymphoma guidance.
Here is what the most important tests in your lymphoma blood work are really telling the team.
The cbc lymphoma panel counts your red cells, white cells and platelets. It is frequently normal in early lymphoma. When abnormal, it can show anaemia, a low platelet count or an unusual white-cell count — sometimes a clue that the marrow is involved, which may prompt a bone marrow biopsy.
A raised LDH can point to a larger or faster-growing lymphoma and feeds into prognostic scoring. It is not specific to lymphoma, so it is always read in context. Our high LDH in lymphoma page explains this marker in detail.
Screening for HIV and hepatitis B and C is routine before systemic therapy. It matters because some lymphoma treatments — such as an anti-CD20 monoclonal antibody — can reactivate a dormant hepatitis B infection unless it is identified and protected against first.
Kidney and liver function, electrolytes and uric acid confirm your organs are healthy enough for treatment and help dose therapy safely. They also give a baseline so the team can watch for any changes once treatment begins.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Worried about a high LDH, an abnormal CBC, or unsure what your lymphoma blood work means? CION's haematology team will read your results in context and explain the next step.
Blood tests are one step in a wider pathway. When someone presents with a persistent, painless swollen lymph node or unexplained symptoms, the team combines several sources of information — and blood work is an early, easy one to gather.
But the decisive step is tissue. As we explain on our can a blood test detect lymphoma? page, bloods can raise or lower suspicion but cannot confirm the disease or its subtype. That requires a biopsy — and specifically, for lymphoma, usually the whole node rather than a fine-needle sample, because the architecture of the node matters. The pathologist then applies immunohistochemistry and, where useful, flow cytometry and immunophenotyping to identify markers such as CD20, CD30 and the cell of origin. Some cases also need molecular and genetic testing to check for features like MYC and BCL2 rearrangements.
In short: your lymphoma blood work sets the scene, but the biopsy and its downstream tests write the diagnosis. If a scan has already flagged an enlarged lymph node, blood tests are usually ordered alongside arranging that biopsy.
Once lymphoma is confirmed, some blood results become part of the planning and prognostic assessment — alongside imaging and the biopsy.
LDH is one of the factors in widely used prognostic indices for non-Hodgkin lymphomas. A raised LDH, together with other clinical features, can indicate a higher-risk disease that may warrant more intensive treatment — while a normal LDH is reassuring but not definitive. It is always weighed with the stage and the amount of bulky disease seen on imaging.
Persistently abnormal counts on the CBC can suggest the marrow is affected. This is confirmed not on bloods but on a bone marrow biopsy when indicated, which contributes to accurate staging.
Kidney, liver and general chemistry results tell the team whether your organs can safely handle systemic therapy and at what dose. This is a practical, safety-first use of blood work that runs right through treatment. CION delivers chemotherapy, immunotherapy and antibody-based therapy, and radiation (IMRT) directly; where a stem-cell transplant is needed, it is coordinated through an accredited partner facility.
Outcomes in lymphoma are often good, and honest published figures matter more than promises. In large published series, Hodgkin lymphoma has an overall survival of roughly 80–90%, and diffuse large B-cell lymphoma — the most common aggressive non-Hodgkin type — around 60–70% with modern treatment. Blood tests such as LDH help estimate risk, but they are only one input. Figures vary by individual, subtype, stage and other factors, and should be discussed with your own specialist. (Source: published survival series referenced in NCCN and ESMO lymphoma guidelines.)
Blood work does not stop once treatment begins — if anything, it becomes more frequent, because it keeps you safe.
Importantly, treatment response is assessed mainly by PET-CT scored on the Deauville scale, not by blood tests. Bloods watch your safety and general trends; the scan judges the lymphoma. CION delivers this monitoring directly as part of coordinated care. To understand how the whole diagnosis comes together, see how doctors identify your lymphoma subtype and understanding your pathology report.
Blood results can be confusing, and a second opinion is especially worthwhile in a few situations:
CION offers a dedicated, free written second-opinion service. Your care should be built around healing, not billing — with transparent costs explained up front. You can also read more about our lymphoma doctors and our lymphoma hospital in Hyderabad. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma team — we'll read your CBC, LDH and viral screen alongside your biopsy and scans, and explain the full picture.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.The starting panel usually includes a complete blood count (CBC) to check red cells, white cells and platelets; a peripheral blood smear where the film is examined under the microscope; and a set of chemistry tests — LDH, uric acid, kidney and liver function, and electrolytes. Doctors often add tests for viruses such as HIV and hepatitis B and C, because these affect treatment planning. Inflammatory markers like ESR may also be checked. This lymphoma blood work does not by itself diagnose lymphoma — that needs a lymph node biopsy — but it builds the clinical picture, flags marrow or organ involvement, and helps set a safe treatment plan. NCCN and ESMO both list these baseline bloods in their lymphoma work-up.
A CBC (complete blood count) measures your red cells, white cells and platelets. In lymphoma the CBC is often normal, especially early on — which is exactly why a normal count never rules lymphoma out. When it is abnormal, it can show anaemia (low haemoglobin), a low or high white-cell count, or a low platelet count (thrombocytopenia). These changes may point to bone-marrow involvement, and a low count can also occur when an enlarged spleen traps blood cells. The CBC also gives a baseline before treatment so the team can monitor how your counts respond and recover. A striking CBC abnormality may prompt a bone marrow biopsy to check whether lymphoma has reached the marrow.
LDH (lactate dehydrogenase) is an enzyme released when cells turn over quickly. In lymphoma a raised LDH can reflect a larger tumour burden or a faster-growing (higher-grade) lymphoma, and it is one of the factors used in prognostic scores that guide treatment intensity. It is not specific — LDH also rises with muscle injury, liver problems, some infections and haemolysis — so it is always read alongside your scans, biopsy and clinical picture, never on its own. A normal LDH does not exclude lymphoma. We explain this marker in depth on our what a high LDH means in lymphoma page. Your CION haematologist interprets LDH in the full context of your diagnosis.
No. Blood tests are important for the work-up, but on their own they cannot confirm lymphoma or its subtype. A confident diagnosis needs tissue — usually an excisional or core biopsy of an affected lymph node — examined by a pathologist with immunohistochemistry and, where needed, flow cytometry. Blood work supports diagnosis by flagging abnormal counts, a high LDH, or marrow or organ involvement, and it can occasionally detect circulating lymphoma cells. But normal bloods are common in lymphoma, so they can never be used to reassure someone that a persistent, unexplained lump is harmless. We cover this fully on our can a blood test detect lymphoma? page.
Screening for HIV and hepatitis B and C is a standard part of the lymphoma blood work, recommended by NCCN and ESMO before systemic treatment begins. There are two reasons. First, these infections can themselves be linked to certain lymphomas and change the treatment approach. Second, some lymphoma therapies — particularly anti-CD20 antibody-based treatment — can reactivate a dormant hepatitis B infection, which can be serious if it is not identified and protected against in advance. Knowing your viral status lets the team add preventive antiviral cover and adjust monitoring where needed. These tests protect you during treatment; they are routine and confidential, and your CION team will explain each result.
Yes. Once treatment starts, regular blood counts track how your body is coping — chemotherapy and antibody therapy can temporarily lower white cells, red cells and platelets, and the CBC guides safe timing of each cycle and the need for supportive care. LDH and organ-function tests are repeated to watch the disease and your kidneys and liver. Blood tests do not replace imaging: response is judged mainly on PET-CT using the Deauville score, not on bloods. In follow-up, unexplained new abnormalities in your counts or LDH may prompt closer review or a scan. CION delivers this monitoring directly as part of coordinated lymphoma care and survivorship.
For most lymphoma blood work no special preparation is needed — a CBC, LDH and viral screen can be taken at any time of day, and you can usually eat and drink normally. Some chemistry panels are easier to interpret if you have not eaten for a few hours, so your team may ask for a short fast; they will tell you in advance if so. Bring a list of your current medicines and any recent results or reports, and mention recent infections, vigorous exercise or muscle injury, as these can nudge markers like LDH. Results are read in context with your pathology report and scans, so your clinician will explain what they mean for your plan rather than any single number in isolation. Book a free consultation if you would like your results reviewed.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.